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SUMMARY Atopic dermatitis (AD) is a relapsing chronic pruritic inflam-
matory disease of skin for which no monogenic cause has been identified 
so far. Meanwhile, the filaggrin (FLG) gene is considered as the most im-
portant gene associated with predisposition to the disease.
One hundred and six patients with AD and 105 healthy individuals were 
enrolled in this study. Real time polymerase chain reaction was performed 
to determine frequencies of alleles and genotype in six variants of the 
FLG gene. The frequencies of allele A in variants of rs3126065, rs2786680, 
and rs1933063 as well as allele C in variant rs3814300 were 100%. There 
was no significant difference between allele frequencies in variants 
rs2485518 and rs3814299. The only genotypes in variants of rs3814299 
and rs2485518 were GG and CC, respectively, with no significant differ-
ence between the patients and controls. This study demonstrated that 
there was no significant association between polymorphisms of FLG 
gene variants and AD. 
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INTRoDUCTIoN
Atopic dermatitis (AD) is defined as a relapsing 
chronic pruritic inflammatory disease of the skin 
which varies in location and form of the involved skin 
as well as different ages of infancy, childhood, and 
adulthood (1). 
Its prevalence was reported to be 0.73% to 23% 
in different studies (2). While there is no countrywide 
study to show the exact prevalence of AD in Iran, 
some local studies showed a prevalence of about 
15% in some areas (3). Although its prevalence varies 
worldwide (4), AD is a major health problem in both 
of developing and developed countries. It has a con-
siderable impact on quality of life and constitutes a 
heavy economic burden (5). It is estimated that AD is 
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responsible for $364 million to $3.8 billion in expen-
ditures in the United States annually (6).
Atopy and atopic march are strongly associated 
with AD (5). Atopic march refers to food allergies in in-
fants followed by AD in first years of life and asthma, 
rhinitis, and other allergic disorders in later years (7).
Although worldwide variation in AD could be sug-
gestive of the influence of environmental factors (7), 
considerable genetic factors were introduced as an-
other etiology (8,9). Indeed, AD is known as a multi-
factorial disease (10).
Recently, Genome Wide Association Studies 
(GWAS) were used in order to investigate genes sus-
pected of causing AD (5) and the whole genome was 
scanned in order to determine genetic variants asso-
ciated with AD (11). Genes with a role in skin barrier 
function were primary candidates in this regard (12).
Epidermal Differentiation Complex (EDC), located 
on chromosome 1q21, is a group of genes involved in 
creation of stratum corneum as the most important 
component of the skin barrier. The filaggrin protein, 
a critical protein in this regard, is encoded by the FLG 
gene and located in EDC (2,7,9,10).
Filaggrin has an important role in moisturizing 
the skin and protecting from penetrating allergens 
(2,4,7). Loss of intact skin barrier, which can be due 
to FLG gene problems, leads to allergen penetra-
tion through the epidermal layer, which causes aller-
gic response and immune sensitization to allergens 
(1,4,5,13).
Recent studies have pointed to an association be-
tween FLG mutations and AD (8), and it is now con-
sidered the most important predisposing gene for 
AD (14,15).
Several studies were performed to evaluate the 
role of Single Nucleotide Polymorphisms (SNPs), lo-
cated on the FLG gene, in susceptibility to AD in dif-
ferent parts of the world (13,16-22). Our study was 
designed to investigate, for the first time, the associa-
tion between 6 functional SNPs in the FLG gene and 
AD among the Iranian population.  
MeThoDS
Subjects
We conducted a case control study among 106 
AD patients and 105 healthy subjects as controls. All 
of the patients were selected from patients with Cau-
casian ethnic group older than 6 months who were 
referred to the Immunology Clinic of the Children’s 
Medical Center Hospital, the Pediatrics Center of Ex-
cellence, Iran, and diagnosed with AD according to 
Hanifin and Rajka’s standard criteria in the Dermatol-
ogy Clinic. Patients with mild AD were excluded from 
the study. Severity of their disease was evaluated by 





























Table 1. Frequencies of alleles and genotypes in different FLG positions in patients with atopic dermatitis 
and controls
202 ACTA DERMATOVENEROLOGICA CROATICA
eczematous skin with pruritis and discharge in the 
most affected areas of the body, depending on the 
patient’s age, was the phenotype of all patients with 
severe AD.
The control group was selected from healthy in-
dividuals without history of atopy who volunteered 
for this study. We attempted to select control subjects 
who were free from any kind of clinical atopy, such as 
rhinitis, asthma, and food allergy. Subjects with per-
sonal or familial history of atopy were excluded from 
the study as well.
This study was approved by the Ethics Commit-
tee of Tehran University of Medical Sciences. Written 
informed consent was signed by the parents of all en-
rolled patients.
Genetic study
Peripheral venous blood sampling was done for 
all the enrolled subjects. Real time polymerase chain 
reaction (PCR) was performed to determine frequen-
cies of alleles and genotypes in six variants of the 
FLG gene, namely rs2485518, rs1933061, rs3126065, 
rs2786680, rs3814300, and rs3814299. These variants 
were selected based on the aforementioned poly-
morphisms in the FLG gene identified by research 
done in other countries. The aim in this study was to 
determine whether the same results would be found 
in Iranian patients.
Statistical Analysis
Allele frequencies of each variant in both patient 
and control groups were determined by direct count-
ing. The odds ratio (OR) and 95% confidence interval 
(CI) were calculated for each allele and genotype. Chi 
square test was used to compare differences between 
the two groups. A P value less than 5% was consid-
ered significant. 
ReSUlTS
As shown in table 1, the frequency of allele A in 
variant rs3126065 was 100% in both of patients and 
controls; none of the individuals had a G allele in this 
variant. Allele A in variants rs2786680 and rs1933063 
and allele C in variant rs3814300 had frequencies of 
100% as well. 
The only genotype in variant rs3814299 was 
GG in both patients and controls. Also, in variant of 
rs2485518, the CC genotype was the dominant geno-
type among both groups.
There was no significant difference in genotype 
frequency in variants rs3814299 and rs2485518. 
DISCUSSIoN
Genetic factors for allergic diseases in the lit-
erature could be categorized into 4 groups. Group 1 
consists of parts of the innate immune system rolled 
in response to environmental exposures; group 2 in-
cludes genes related to skin barrier function; group 
3 consists of factors affecting the adaptive immune 
system; and finally group 4 is comprised of  factors 
modifying the tissue response to inflammation (8).
Although most prior studies focused on the in-
nate and adaptive immune systems, recent studies 
were directed at genes related to epidermal barrier 
dysfunction in order to evaluate the pathophysiology 
of the disease (23).
Skin barrier dysfunction is considered one of the 
most important etiologies of allergic diseases, includ-
ing AD. Stratum corneum and its tight junctions in 
the epidermal layer of the skin have an important role 
in acting as skin barrier. 
Loricrin, involucrin, S100 gene family, small pro-
line-rich proteins, peptidoglycan proteins, and filag-
grin are some of the proteins coded in the EDC locus 
on chromosome 1q216, and their problems are as-
sociated with skin barrier dysfunction. FLG has been 
widely studied in literature in this regard (12).
Palmer et al. (16) reported for the first time that 
impaired epidermal barrier due to mutation on the 
FLG gene could predispose patients to AD. 
The study done by Sugiura et al., (24) who evaluat-
ed some gene expressions in skin biopsy specimens 
of patients with, revealed down regulation of FLG 
mRNA in patients with AD compared to the controls. 
Many of these studies are restricted to studying 
those two null mutations of R501X (rs61816761) and 
2282del4 investigated by Palmer et al., but full se-
quencing of FLG has demonstrated polymorphisms 
with different frequencies in different races (12).
These mutations have been shown to predispose 
the Caucasian population to AD; however, these mu-
tations were not found in non-European populations 
such as Asian or African ethnic groups (2). This is in 
agreement with the findings of the study by Nomura 
et al. (25) who found two novel mutations in Japanese 
patients, 3321delA and S2554X, rather than R501X 
and 2282del4. Winge et al. (26) conducted a study 
among Ethiopian patients with AD, in which the FLG 
mutation of R501X, 2282del4, S3247X, R2447X was 
not seen. 
CoNClUSIoN
Our study showed that all of the patients enrolled 
in this study had the same allele in variants rs1933061, 
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rs3126065, rs2786680, rs3814300, rs2485518, and 
rs3814299. Our findings regarding the variants listed 
suggest that these variants should not be considered 
SNPs among the Iranian population. However, more 
studies with a larger sample size could increase the 
power of this result. 
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